Bufei Yishen formula ameliorates chronic obstructive pulmonary disease by restoring alveolar macrophage efferocytosis through Nrf2 activation.
ETHNOPHARMACOLOGICAL RELEVANCE Bufei Yishen formula (BYF) is a traditional Chinese medicine (TCM) prescription clinically used to improve pulmonary function and quality of life in patients with stable chronic obstructive pulmonary disease (COPD). However, its mechanism in regulating alveolar macrophage dysfunction rema...